3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
47
Recurrence
10
Neoplasms, Plasma Cell
5
Sarcoma
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Non-Hodgkin
2
Waldenstrom Macroglobulinemia
1
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Smoldering Multiple Myeloma
1
Sarcoma, Clear Cell
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms
1
Neoplasm, Residual
1
Myoepithelioma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Large B-Cell, Diffuse
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Interventions
Dexamethasone
50
Melphalan
29
Cyclophosphamide
25
Bortezomib
24
Filgrastim
18
Calcium Dobesilate
18
Peripheral Blood Stem Cell Transplantation
16
daratumumab
13
pomalidomide
10
dexamethasone acetate
8
Lenalidomide
8
fludarabine phosphate
7
ixazomib
6
dexamethasone 21-phosphate
6
Whole-Body Irradiation
6
Mycophenolic Acid
6
venetoclax
5
birtamimab
5
auricularum
5
Thalidomide
5
Granulocyte Colony-Stimulating Factor
5
Cyclosporine
5
Busulfan
5
Radiotherapy
4
Interferon-alpha
4
Etoposide
4
Carboplatin
4
Biopsy
4
sargramostim
3
miridesap
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
selinexor
×
Plasma cell
×
Clear all
NCT04984330
2022-11-17
STARR
Weill Medical College of Cornell University
Phase EARLY_PHASE1
Withdrawn